Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Titanium Transportation Group Inc, together with its subsidiaries, provides asset-based transportation and logistics services in North America. It operates in two segments, Truck Transportation ...

Study results support the role of functional dystrophin and suggest that delandistrogene moxeparvovec stabilizes or slows ...

Titanium Transportation Group Inc. (CVE:TTR – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.44 and traded as ...

As you may recall, this pivotal trial is an efficient study with expected enrollment of 50 patients. We plan to measure mNIS+7 at 18 months, and serum TTR levels as key endpoints in the study.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Investing.com -- Alnylam Pharmaceuticals (NASDAQ: NASDAQ: ALNY) stock climbed 5% as trading resumed on Friday morning, following the company’s announcement that the FDA has approved AMVUTTRA for ...

"As we advance our flagship TTR franchise, we are excited to share Phase 3 development plans for our next-generation TTR silencer, nucresiran, which has best-in-class potential. We are also ...

Buy your chance to win cash prizes, while benefitting community and youth activities of Rotary Club of Lake Mills. For every ticket you purchase for yourself or a friend ($50 each), your/their name ...

Time to Rise (TTR) and 10-meter walk/run (10MWR) function tests compared with a pre-specified, propensity-weighted external control group. In June 2024, the FDA approved the labeled indication for ...